InvestorsHub Logo
Followers 59
Posts 7365
Boards Moderated 0
Alias Born 10/20/2014

Re: Birdbrain Ideas post# 373117

Wednesday, 03/16/2022 4:21:05 PM

Wednesday, March 16, 2022 4:21:05 PM

Post# of 423624
Birdbrain, Honestly, I believe Mochida's Once a day pill may be more
important unless it could also be part of a combo pill with a statin.
In the very near term I think if Pfizer were to acquire AMRN they could
relaunch a rebranded Vascepa which could even be a branded generic.
AMRN management has failed to gain the traction that all of us had
hoped for. My faith would be with BP such as Pfizer that has the
"gravitas" to successfully relaunch Vascepa.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News